Future Perspectives on PAT & QbD Utilisation

Add bookmark
In this interview Sune Klint Andersen,Principal Scientist in Drying Processes and Particle Technology in CMC at Novo Nordisk A/S, Denmark, shares his future perspectives on process analytical technology (PAT) & quality by design (QbD) utilisation. Klint Andersen also discusses what impact QbD has on process understanding, product development and product quality and the main challenges encountered when adopting QbD. Pharma IQ: What is meant by Quality by Design and what are the key busi...

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended